Publication | Closed Access

Combination of tumour-infarction therapy and chemotherapy via the co-delivery of doxorubicin and thrombin encapsulated in tumour-targeted nanoparticles

NanoparticlesNanomedicineTumour-targeted NanoparticlesEngineeringTherapeutic NanomaterialsMedicineTumour-infarction TherapyNano-drug DeliveryTumor TargetingBiomedical EngineeringPharmacologyTumor Microenvironment